Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ocuphire Pharma, Inc. | Chief Financial Officer | Common Stock | 150K | $315K | $2.10 | Mar 21, 2024 | Direct |
Ocuphire Pharma, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 210K | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUP | Ocuphire Pharma, Inc. | Mar 21, 2024 | 1 | $21K | 4 | Mar 25, 2024 | Chief Financial Officer |
OCUP | Ocuphire Pharma, Inc. | Feb 12, 2024 | 2 | $0 | 4 | Feb 14, 2024 | Chief Financial Officer |
OCUP | Ocuphire Pharma, Inc. | Feb 12, 2024 | 0 | $0 | 3 | Feb 14, 2024 | Chief Financial Officer |